# PCO-02 - Safety and Pharmacokinetics Trial

> **NCT02637284** · PHASE1 · UNKNOWN · sponsor: **PharmaCotherapia d.o.o.** · enrollment: 42 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Bepecin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02637284
- **Lead sponsor:** PharmaCotherapia d.o.o.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2015-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02637284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02637284, "PCO-02 - Safety and Pharmacokinetics Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02637284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
